Higher Thrombelastograph platelet reactivity in cardiac surgery patients than in blood donors

Scandinavian Cardiovascular Journal

Volumn 41, Issue 5, 2007, Pages 321-324

  Bochsen, Louise ^a   Nielsen, Allan Bybeck ^a   Steinbrüchel, Daniel A ^a   Johansson, Pär I ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

CABG; Platelet mapping; Platelet reactivity; Thrombelastograph

Indexed keywords

ADENOSINE DIPHOSPHATE;

ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; BLOOD SAMPLING; CELL ACTIVITY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; PATIENT IDENTIFICATION; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REFERENCE VALUE; RISK ASSESSMENT; SURGICAL PATIENT; THROMBOCYTE FUNCTION; THROMBOELASTOGRAPHY;

BLOOD COAGULATION; BLOOD DONORS; CASE-CONTROL STUDIES; CORONARY ARTERY BYPASS; HUMANS; MYOCARDIAL ISCHEMIA; PLATELET FUNCTION TESTS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; THROMBELASTOGRAPHY; TIME FACTORS;

EID: 34748915838     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.1080/14017430701225923     Document Type: Article

References (16)

1. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group (1988) Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. J Am CollCardiol, 12:6, pp. 3A-13A.
2. Antithrombotic Trialists' Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ, 324:7329, pp. 71-86.
3. CAPRIE Steering Committee (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet, 348:9038, pp. 1329-1339.
4. Hirsh, J. and Bhatt, DL. (2004) Comparative benefits of clopidogrel and aspirin in high-risk patient populations: Lessons from the CAPRIE and CURE studies. Arch Intern Med., 164, pp. 2106-2110.
5. Serebruany, VL, Steinhubl, SR, Berger, PB, Malinin, AI, Bhatt, DL and Topol, EJ. (2005) Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol., 45, pp. 246-251.
6. Jaremo, P., Lindahl, TL, Fransson, SG and Richter, A. (2002) Individual variations of platelet inhibition after loading doses of clopidogrel. J Intern Med., 252, pp. 233-238.
7. Chu, MW, Wilson, SR, Novick, RJ, Stitt, LW and Quantz, MA. (2004) Does clopidogrel increase blood loss following coronary artery bypass surgery?. Ann Thorac Surg., 78, pp. 1536-1541.
8. Chen, L., Bracey, AW, Radovancevic, R., Cooper Jr, JR, Collard, CD and Vaughn, WK (2004) Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting. J Thorac Cardiovasc Surg., 128, pp. 425-431.
9. Gurbel, PA, Bliden, KP, Guyer, K., Cho, PW, Zaman, KA and Kreutz, RP (2005) Platelet reactivity in patients and recurrent events post-stenting: Results of the PREPARE POST-STENTING Study. J Am Coll Cardiol., 46, pp. 1820-1826.
10. Craft, RM, Chavez, JJ, Bresee, SJ, Wortham, DC, Cohen, E. and Carroll, RC. (2004) A novel modification of the Thrombelastograph assay, isolating platelet function, correlates with optical platelet aggregation. J Lab Clin Med., 143, pp. 301-309.
11. Craft, RM, Chavez, JJ, Snider, CC, Muenchen, RA and Carroll, RC. (2005) Comparison of modified Thrombelastograph and Plateletworks whole blood assays to optical platelet aggregation for monitoring reversal of clopidogrel inhibition in elective surgery patients. J Lab Clin Med., 145, pp. 309-315.
12. McCrath, DJ, Cerboni, E., Frumento, RJ, Hirsh, AL and Bennett-Guerrero, E. (2005) Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg., 100, pp. 1576-1583.
13. Wohltmann, CD, Franklin, GA, Boaz, PW, Luchette, FA, Kearney, PA and Richardson, JD (2001) A multicenter evaluation of whether gender dimorphism affects survival after trauma. Am J Surg., 181, pp. 297-300.
14. Schreiber, MA, Differding, J., Thorborg, P., Mayberry, JC and Mullins, RJ. (2005) Hypercoagulability is most prevalent early after injury and in female patients. J Trauma., 58, pp. 475-480.
15. Panzer, S., Hocker, L. and Koren, D. (2006) Agonists-induced platelet activation varies considerably in healthy male individuals: Studies by flow cytometry. Ann Hematol., 85, pp. 121-125.
16. Hanjis, C., Frishman, WH and Lerner, RG. (2006) Aspirin resistance: Mechanisms and clinical implications. Cardiol Rev., 14, pp. 18-25.